in Newswire May 3, 2021

Aspercreme Is Falsely Advertised, Class Action Lawsuit Alleges

by Corrado Rizzi

Last Updated on May 3, 2021

Cruz v. Sanofi US Corporation

Filed: May 1, 2021 § 1:21-cv-02351

A class action alleges the maker of Aspercreme has misrepresented the lidocaine-based pain-reliever through “affirmative statements, half-truths, and omissions.”

Last Updated on May 3, 2021 — 5:05 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.